DexCom is transforming into the premium CGM provider with the lowest cost per patient-day and robust clinical evidence. Read ...
In der CONNECT-Studie erzielten Teilnehmende ohne Insulintherapie mit CGM nach 26 Wochen niedrigere HbA1c-Werte als unter ...
A Type 2 diabetes patient prepares to attach his Dexcom sensor, part of a continuous glucose monitoring system, on his stomach at his home in Glenarden, Maryland, U.S., July 15, 2021. REUTERS/Hannah ...
Today we highlight a study that found benefits of wearable glucose monitoring devices for all patients with diabetes, ...
Redactada por César Nuez y redaccion@vortexmedia.es Buena figura en Dexcom que terminó el jueves con unas subidas del 5,07%.
A new methodological perspective uses the Sinocare iCan i3 real-world accuracy study to argue that continuous glucose ...
Domestic pharmaceutical companies continue to enter the continuous glucose monitoring, CGM, business. As Daewoong ...
KurzüberblickDie CONNECT-Studie untersuchte DexComs G7 bei Erwachsenen mit Typ-2-Diabetes, die kein Insulin verwenden.Mit dem ...
The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare ...
und zwar seit der Entstehung dieser CGM-Kategorie. Die randomisierte kontrollierte Studie zeigt, dass Dexcom G7 den A1C-Wert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results